Evaluating Cross-Cutting Prevention at the U.S. Air Force Academy

November 21, 2025 updated by: Marni Kan, RTI International

Evaluating Cross-Cutting Sexual Assault and Alcohol Misuse Prevention Programming at the U.S. Air Force Academy

Sexual assault and alcohol misuse are interrelated, persist at high rates in military populations, and carry negative consequences for military units and personnel. Combining tailored efforts to prevent sexual assault and alcohol misuse is critical for developing a more effective Force. This study will test the cross-cutting immediate and long-term outcomes of two programs, the Sexual Communication and Consent (SCC) sexual assault prevention program and the eCHECKUP TO GO alcohol misuse prevention program, delivered separately and in combination, with Cadets at the United States Air Force Academy. Anonymous Cadet self-report data will be collected before training (pre-test), immediately after training (post-test), 3 months after training (Fall semester follow-up), and 9 months after training (Spring semester follow-up).

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Sexual assault and alcohol misuse both persist at high rates among military populations. These behaviors interfere with readiness, unit cohesion, mission objectives, and personnel performance and retention. There are demonstrated associations between sexual assault and alcohol misuse for both perpetrators and victims of sexual assault. Therefore, combining efforts to prevent sexual assault and alcohol misuse is critical for more effective and efficient programming. Moreover, tailored prevention programming that addresses individual risks and experiences related to sexual assault and alcohol misuse is likely to be the most effective programming. Unfortunately, to date, no evidence-based cross-cutting interventions have been developed and evaluated for impacts on both sexual assault and alcohol misuse among military populations. Several challenges impede this effort. Sexual assault prevention and alcohol misuse prevention are typically managed in different organizations within military settings, including within Military Service Academies. Training settings face many competing demands for trainees' time and instructor capacity, and instructors' ability to provide both sexual assault-related and alcohol-related training varies widely. Despite the promise of tailored training, individualized programming also presents feasibility challenges in group education settings common to military training. In alignment with the Fiscal Years 2021-2025 Department of Defense (DoD) Sexual Assault Prevention and Response (SAPR) Research Agenda and DoD's desire to have cross-cutting prevention programs that reduce risk for multiple harmful behaviors, the long-term goal of the proposed work is to address these challenges and provide the military with flexible, engaging, tailored prevention programming that reduces sexual assault and alcohol misuse while minimizing burden on Service members and training settings. To that end, the basic objective of this study is to test the cross-cutting immediate and long-term outcomes of two programs, the Sexual Communication and Consent (SCC) sexual assault prevention program and the eCHECKUP TO GO alcohol misuse prevention program, delivered separately and in combination, with Cadets at the United States Air Force Academy. Anonymous Cadet self-report data will be collected before training (pre-test), immediately after training (post-test), 3 months after training (Fall semester follow-up), and 9 months after training (Spring semester follow-up).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
2041

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Colorado
      • Air Force Academy, Colorado, United States, 80840
        • United States Air Force Academy

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • U.S. Air Force Academy Basic Cadet enrolled in 2022 or 2023 Basic Cadet Training

Exclusion Criteria:

  • Unable or unwilling to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Active Comparator: Training as usual (TAU)
TAU without SCC or eCHECKUP TO GO
Behavioral: Training as usual (TAU)
TAU involves universal classroom instruction focused on developing knowledge, attitudes, and skills to promote personal resilience, increase potential for success, and develop healthy and rewarding personal relationships.
Experimental: TAU plus eCHECKUP TO GO
TAU with eCHECKUP TO GO (without SCC)
Behavioral: Training as usual (TAU)
TAU involves universal classroom instruction focused on developing knowledge, attitudes, and skills to promote personal resilience, increase potential for success, and develop healthy and rewarding personal relationships.
Behavioral: Alcohol eCHECKUP TO GO (eCHECKUP TO GO)
eCHECKUP TO GO is a personalized, online intervention designed to reduce cognitive risk factors for alcohol misuse. eCHECKUP TO GO is brief, self-guided, and provides individualized feedback based on a user's self-reported alcohol use patterns and consequences.
Experimental: SCC
SCC without TAU or eCHECKUP TO GO
Behavioral: Sexual Communication and Consent (SCC)
SCC combines universal classroom instruction with tailored web-based content. Based on sociodemographic characteristics and prior sexual assault experiences, Cadets receive tailored content that addresses either primary victimization prevention, revictimization prevention, or healthy relationships and bystander intervention promotion.
Experimental: SCC plus eCHECKUP TO GO
SCC with eCHECKUP TO GO (without TAU)
Behavioral: Alcohol eCHECKUP TO GO (eCHECKUP TO GO)
eCHECKUP TO GO is a personalized, online intervention designed to reduce cognitive risk factors for alcohol misuse. eCHECKUP TO GO is brief, self-guided, and provides individualized feedback based on a user's self-reported alcohol use patterns and consequences.
Behavioral: Sexual Communication and Consent (SCC)
SCC combines universal classroom instruction with tailored web-based content. Based on sociodemographic characteristics and prior sexual assault experiences, Cadets receive tailored content that addresses either primary victimization prevention, revictimization prevention, or healthy relationships and bystander intervention promotion.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Self-reported Sexual Assault Victimization
Time Frame: From pre-test to Spring semester follow-up, an average of 10 months
Participants self-report whether they experienced any type of unwanted sexual contact between Basic Cadet Training and the Spring semester follow-up using a modified version of the Sexual Experiences Survey.
From pre-test to Spring semester follow-up, an average of 10 months
Self-reported Sexual Assault Perpetration
Time Frame: From pre-test to Spring semester follow-up, an average of 10 months
Participants self-report whether they perpetrated any type of unwanted sexual contact between Basic Cadet Training and the Spring semester follow-up using a modified version of the Sexual Experiences Survey.
From pre-test to Spring semester follow-up, an average of 10 months
Self-reported Alcohol Use
Time Frame: From pre-test to Spring semester follow-up, an average of 10 months
Participants self-report the approximate number of alcoholic drinks they consumed each day of the week during a typical week over the past month (assessed at both the Fall and Spring semester follow-up assessments). Participants who respond with any weekly value greater than 0 alcoholic drinks at either the Fall or Spring semester follow-up are coded as positive for any alcohol use.
From pre-test to Spring semester follow-up, an average of 10 months

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Knowledge of Sexual Assault
Time Frame: From pre-test to post-test, an average of 1 month
The percentage of correct participant responses to 8 true-or-false questions about sexual assault.
From pre-test to post-test, an average of 1 month
Knowledge of Effective Consent
Time Frame: From pre-test to post-test, an average of 1 month
The percentage of correct participant responses to 7 true-or-false questions about effective sexual consent.
From pre-test to post-test, an average of 1 month
Self-efficacy to Resist Unwanted Sexual Advances
Time Frame: From pre-test to post-test, an average of 1 month
A subset of participants rate their degree of confidence in their ability to use certain protective strategies in 6 specific high-risk situations. Scale scores range 6 to 42, with higher scores indicating greater self-efficacy.
From pre-test to post-test, an average of 1 month
Normative Perceptions of Peer Alcohol Use
Time Frame: From pre-test to post-test, an average of 1 month
Participants report how many days in the week they estimate the average Cadet of their same age and gender drinks and how many drinks the average Cadet of their same age and gender consumes per day using a modified version of the Quantity/Frequency/Peak questionnaire. The average number of estimated drinks consumed per drinking day is computed from this data and has a possible score range of 0 drinks to 6 drinks.
From pre-test to post-test, an average of 1 month
Readiness to Change Alcohol Use Behavior
Time Frame: From pre-test to post-test, an average of 1 month
Participants self-report their readiness to change their drinking behavior using a single item. The possible item score ranges 0 to 4, with higher scores indicating greater readiness to change.
From pre-test to post-test, an average of 1 month
Dating-related Protective Strategy Use
Time Frame: From pre-test to Spring semester follow-up, an average of 10 months
Participants self-report the degree to which they engaged in behavioral strategies to reduce sexual assault risk using the Dating Self-Protection Against Rape Scale. Scores range 0 to 70, with higher scores indicating greater engagement in dating-related protective behavioral strategies.
From pre-test to Spring semester follow-up, an average of 10 months
Alcohol-related Protective Strategy Use
Time Frame: From pre-test to Spring semester follow-up, an average of 10 months
Participants self-report the degree to which they engaged in behavioral strategies to reduce alcohol-related harms using an adapted version of the Protective Behavioral Strategies Survey. Scores range 0 to 100, with higher scores indicating greater engagement in alcohol-related protective strategies.
From pre-test to Spring semester follow-up, an average of 10 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
RTI International

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
San Diego State University
United States Department of Defense
University of Florida
U.S. Army Medical Research and Development Command
U.S. Army Medical Research Acquisition Activity

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Marni L Kan, PhD, RTI International
  • Principal Investigator: Nichole M Scaglione, PhD, University of Florida
  • Principal Investigator: Emily A Schmied, PhD, San Diego State University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
June 27, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 1, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 1, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
March 3, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
March 7, 2025

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
March 13, 2025

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
November 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
November 21, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 0218275.001.001.003
  • W81XWH-21-9-0011.012 (Other Grant/Funding Number: U.S. Army Medical Research and Development Command)
  • W81XWH-20-2-0014 (Other Grant/Funding Number: The Department of Defense's Office of Congressionally Directed Medical Research Programs)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings